Genitourinary Radiology: Page 16

Blue Earth points to Axumin studies at ASCO meeting

By AuntMinnie.com staff writers

Bracco molecular imaging subsidiary Blue Earth Diagnostics announced that several abstracts evaluating its PET radiotracer Axumin (fluciclovine F-18) for imaging men with suspected prostate cancer will be presented June 4 at the 2021 American Society of Clinical Oncology (ASCO) virtual annual meeting.

June 2, 2021

Shorter lung ultrasound exams can help kidney disease patients

By Amerigo Allegretto

Lung ultrasound with an abbreviated scanning protocol can efficiently diagnose pulmonary congestion caused by fluid overload in hemodialysis patients, according to research published June 3 in the American Journal of Kidney Diseases.

June 2, 2021

Ultrasound AI model can help evaluate chronic kidney disease

By Erik L. Ridley

Artificial intelligence (AI)-based analysis of kidney ultrasound studies could serve as a first-line method for evaluating patients with chronic kidney disease, according to research published online May 24 in JAMA Network Open.

May 23, 2021

Is mpMRI equally available to all men at risk of prostate cancer?

By Kate Madden Yee

Multiparametric MRI (mpMRI) is an effective screening tool for prostate cancer, but not all eligible patients are receiving it -- especially Black men, who tend to have higher rates of the disease, according to a study published May 19 in Academic Radiology.

May 20, 2021

USPSTF lowers starting age for colon cancer screening

By AuntMinnie.com staff writers

The U.S. Preventive Services Task Force (USPSTF) has released a colon cancer screening guideline that lowers the starting age from 50 to 45. The guidance was published on May 18 in JAMA.

May 18, 2021

RSIP Vision debuts prostate AI registration tool

By AuntMinnie.com staff writers

Computer software and artificial intelligence (AI) company RSIP Vision has unveiled a prostate MRI and ultrasound fusion AI software application.

May 6, 2021

Lantheus subsidiary Exini secures CE Mark for PET/CT prostate software

By AuntMinnie.com staff writers

Lantheus Holdings subsidiary Exini Diagnostics has secured the CE Mark for aPromise, an artificial intelligence software that helps clinicians assess prostate-specific membrane antigen PET/CT exams.

May 2, 2021

Groups launch registry to promote SPECT for prostate cancer

By AuntMinnie.com staff writers

The Oncidium Foundation and Telix Pharmaceuticals have launched a registry to promote the use of SPECT with a prostate-specific membrane antigen agent for prostate cancer detection.

April 20, 2021

Hoag launches PET trials for prostate cancer, myeloma

By AuntMinnie.com staff writers

Hoag Family Cancer Institute is launching two new clinical trials for PET radiotracers: a myeloma imaging trial in the U.S. and a prostate cancer molecular therapy trial in Orange County, CA.

April 20, 2021

Brain imaging with CT, MRI in kidney cancer patients finds metastases

By AuntMinnie.com staff writers

Baseline brain imaging using CT or MRI in patients with metastatic kidney cancer can identify brain metastases before symptoms appear, according to a study published in the April issue of the Journal of the National Comprehensive Cancer Network.

April 13, 2021

Exposure to contrast on CTPA doesn't cause long-term kidney injury

By Kate Madden Yee

Exposure to intravenous contrast via CT pulmonary angiogram (CTPA) exams does not appear to cause long-term kidney injury, according to a study published April 5 in JAMA Internal Medicine.

April 8, 2021

GE adds new compact POCUS system, AI software

By AuntMinnie.com staff writers

GE Healthcare has broadened its Venue point-of-care ultrasound (POCUS) product line with a new compact system, as well as new artificial intelligence (AI) applications for its existing Venue and Venue Go units.

March 29, 2021

Previous Page

Page 16 of 93

Next Page